Hu Yuhe, Li Yuying
Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Zhongguo Fei Ai Za Zhi. 2024 Feb 20;27(2):96-101. doi: 10.3779/j.issn.1009-3419.2024.102.07.
Lung cancer is a common malignant tumor of respiratory system. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a valuable tool for the diagnosis and staging of lung cancer. EBUS-TBNA is predominantly performed under local anesthesia or conscious sedation. However, the diagnostic performance of EBUS-TBNA under general anesthesia and in conjunction with rapid on-site evaluation (ROSE) remains uncertain. This study aims to investigate the value of general anesthesia and ROSE in the diagnosis of lung cancer with EBUS-TBNA.
A retrospective analysis was conducted on 164 patients treated in the Department of Respiratory and Critical Care Medicine of The Affiliated Hospital of Southwest Medical University from January 2018 to December 2022. All patients were preoperatively suspected of lung cancer and underwent EBUS-TBNA. Based on whether they received general anesthesia and ROSE, the patients were divided into three groups: local anesthesia group (LA group)(n=54), general anesthesia group (GA group)(n=67) and general anesthesia with ROSE group (GA-ROSE group)(n=43). The puncture characteristics and diagnostic differences were analyzed among the groups.
The number of lymph node puncture needles in the LA group was higher than in GA-ROSE group (P<0.01). The overall diagnostic rates of EBUS-TBNA for the three groups were 87.04%, 89.55% and 90.70%, respectively, with malignant tumor diagnostic rates of 88.24%, 88.89% and 94.74%. No statistically significant differences were observed among the three groups (P>0.05). There were no instances of severe complications or adverse anesthesia reactions in any of the groups.
Compared to the combination of local anesthesia with intravenous analgesia and sedation, the implementation of EBUS-TBNA under general anesthesia, with or without ROSE, achieves equally accurate results, and general anesthesia combined with ROSE can reduce in the number of lymph node puncture needles.
肺癌是呼吸系统常见的恶性肿瘤。超声支气管镜引导下经支气管针吸活检术(EBUS-TBNA)是肺癌诊断和分期的重要工具。EBUS-TBNA主要在局部麻醉或清醒镇静下进行。然而,全身麻醉联合快速现场评估(ROSE)下EBUS-TBNA的诊断性能仍不确定。本研究旨在探讨全身麻醉和ROSE在EBUS-TBNA诊断肺癌中的价值。
回顾性分析2018年1月至2022年12月在西南医科大学附属医院呼吸与危重症医学科接受治疗的164例患者。所有患者术前均怀疑患有肺癌并接受了EBUS-TBNA。根据是否接受全身麻醉和ROSE,将患者分为三组:局部麻醉组(LA组)(n=54)、全身麻醉组(GA组)(n=67)和全身麻醉联合ROSE组(GA-ROSE组)(n=43)。分析各组间的穿刺特征和诊断差异。
LA组的淋巴结穿刺针数高于GA-ROSE组(P<0.01)。三组EBUS-TBNA的总体诊断率分别为87.04%、89.55%和90.70%,恶性肿瘤诊断率分别为88.24%、88.89%和94.74%。三组间差异无统计学意义(P>0.05)。所有组均未出现严重并发症或麻醉不良反应。
与局部麻醉联合静脉镇痛镇静相比,全身麻醉下实施EBUS-TBNA(无论是否联合ROSE)均能获得同样准确的结果,且全身麻醉联合ROSE可减少淋巴结穿刺针数。